New subtype of ovarian cancer may be vulnerable to anti-angiogenic drugs
BOSTON--Scientists at Dana-Farber Cancer Institute have identified a subtype of ovarian cancer able to build its own blood vessels, suggesting that such tumors might be especially susceptible to "anti-angiogenic" drugs that ...
Feb 14, 2012
0
0